- Home
- TNYA vs DHIL Comparison
TNYA vs DHIL Comparison
Compare TNYA & DHIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNYA
- DHIL
- Stock Information
- Founded
- TNYA 2016
- DHIL 1990
- Country
- TNYA United States
- DHIL United States
- Employees
- TNYA N/A
- DHIL N/A
- Industry
- TNYA Medicinal Chemicals and Botanical Products
- DHIL Investment Managers
- Sector
- TNYA Health Care
- DHIL Finance
- Exchange
- TNYA Nasdaq
- DHIL Nasdaq
- Market Cap
- TNYA 326.0M
- DHIL 384.0M
- IPO Year
- TNYA 2021
- DHIL 1995
- Fundamental
- Price
- TNYA $1.27
- DHIL $127.23
- Analyst Decision
- TNYA Strong Buy
- DHIL
- Analyst Count
- TNYA 5
- DHIL 0
- Target Price
- TNYA $8.60
- DHIL N/A
- AVG Volume (30 Days)
- TNYA 3.9M
- DHIL 28.0K
- Earning Date
- TNYA 11-10-2025
- DHIL 10-30-2025
- Dividend Yield
- TNYA N/A
- DHIL 4.74%
- EPS Growth
- TNYA N/A
- DHIL N/A
- EPS
- TNYA N/A
- DHIL 17.21
- Revenue
- TNYA N/A
- DHIL $149,665,296.00
- Revenue This Year
- TNYA N/A
- DHIL N/A
- Revenue Next Year
- TNYA N/A
- DHIL N/A
- P/E Ratio
- TNYA N/A
- DHIL $7.42
- Revenue Growth
- TNYA N/A
- DHIL 2.65
- 52 Week Low
- TNYA $0.36
- DHIL $122.32
- 52 Week High
- TNYA $4.01
- DHIL $172.84
- Technical
- Relative Strength Index (RSI)
- TNYA 39.57
- DHIL 33.07
- Support Level
- TNYA $1.20
- DHIL $130.11
- Resistance Level
- TNYA $1.56
- DHIL $133.58
- Average True Range (ATR)
- TNYA 0.14
- DHIL 2.51
- MACD
- TNYA -0.02
- DHIL -0.04
- Stochastic Oscillator
- TNYA 16.67
- DHIL 32.09
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
About DHIL Diamond Hill Investment Group Inc.
Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.